INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,677,560 | +24.5% | 306,233 | -25.7% | 0.03% | +26.9% |
Q2 2023 | $4,559,750 | +30.4% | 412,274 | +58.3% | 0.03% | +8.3% |
Q1 2023 | $3,497,508 | +6.3% | 260,425 | -2.1% | 0.02% | -14.3% |
Q4 2022 | $3,289,393 | +4.5% | 265,917 | +17.9% | 0.03% | -15.2% |
Q3 2022 | $3,147,000 | +48.7% | 225,604 | +47.3% | 0.03% | +73.7% |
Q2 2022 | $2,116,000 | -42.9% | 153,193 | -32.8% | 0.02% | -13.6% |
Q1 2022 | $3,707,000 | -12.4% | 227,843 | -12.3% | 0.02% | 0.0% |
Q4 2021 | $4,233,000 | +93.1% | 259,839 | +76.0% | 0.02% | +46.7% |
Q3 2021 | $2,192,000 | -9.3% | 147,600 | +22.0% | 0.02% | 0.0% |
Q2 2021 | $2,416,000 | -34.0% | 120,991 | -23.7% | 0.02% | -40.0% |
Q1 2021 | $3,660,000 | +388.0% | 158,592 | +422.5% | 0.02% | +257.1% |
Q4 2020 | $750,000 | -62.0% | 30,355 | -36.2% | 0.01% | -70.8% |
Q3 2020 | $1,973,000 | +224.0% | 47,581 | +274.5% | 0.02% | +166.7% |
Q2 2020 | $609,000 | +150.6% | 12,704 | +229.3% | 0.01% | -10.0% |
Q1 2020 | $243,000 | -94.0% | 3,858 | -88.3% | 0.01% | -84.1% |
Q4 2019 | $4,073,000 | -34.8% | 32,865 | -65.1% | 0.06% | -35.7% |
Q3 2019 | $6,244,000 | +26.2% | 94,097 | +51.3% | 0.10% | +12.6% |
Q2 2019 | $4,947,000 | -10.0% | 62,176 | +26.5% | 0.09% | -1.1% |
Q1 2019 | $5,496,000 | – | 49,135 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
CM Management, LLC | 45,000 | $668,000 | 0.50% |
EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |